A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis-Reference-Cited by-同舟云学术

A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis

Published:2017-11-17 Issue:2 Volume:93 Page:E33-E35
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Minetto Paola¹^ORCID,Guolo Fabio¹^ORCID,Clavio Marino¹,Kunkl Annalisa²,Colombo Nicoletta¹,Carminati Enrico¹,Giannoni Livia¹,Ballerini Filippo¹,Lemoli Roberto Massimo¹,Gobbi Marco¹,Miglino Maurizio¹

Affiliation:

1. Clinic of Hematology, Department of Internal Medicine (DiMI); University of Genoa, Policlinico San Martino, IRCCS per l'Oncologia; Genoa Italy

2. Clinical Flow Cytometry Unit, Anatomic Pathology, Policlinico San Martino, IRCCS per l'Oncologia; Genoa Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24956/fullpdf

Reference6 articles.

1. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations;Döhner;Blood.,2005

2. High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: a critical review of a 10-year, single-center experience in younger, non M3 AML patients;Guolo;Am J Hematol.,2016